Novavax宣布，Ruxandra Draghia-Akli醫學(xue)博士(shi)(shi)將于2024年(nian)11月加入(ru)公(gong)司，擔(dan)任執(zhi)行副總(zong)裁兼(jian)研(yan)發(fa)(R&D)主(zhu)(zhu)管。Draghia-Akli博士(shi)(shi)最近(jin)曾擔(dan)任強生公(gong)司全(quan)(quan)球公(gong)共(gong)衛生研(yan)發(fa)部(bu)門的(de)全(quan)(quan)球主(zhu)(zhu)管，帶頭推動(dong)了多(duo)個疾病領域(yu)的(de)藥物(wu)發(fa)現和開發(fa)，此(ci)前，Draghia-Akli博士(shi)(shi)還曾擔(dan)任默沙(sha)東公(gong)司全(quan)(quan)球疫苗副總(zong)裁。(美通社(she))